TARO-SITAGLIPTIN FUMARATE

Identification of Taro-Sitagliptin Fumarate

No description

Google image searchProduct monograph

Active ingredient

sitagliptin (sitagliptin fumarate), 25 MG

DIN: 02531631

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: TARO PHARMACEUTICALS INC

Date: 05-JAN-2023

ATC:

• A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
• A10B — BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS (ATC, ATC/DDD)
• A10BH — Dipeptidyl peptidase 4 (DPP-4) inhibitors (ATC, ATC/DDD)
• A10BH01 — SITAGLIPTIN (ATC/DDD)

Reference brand drug: Januvia

External Links for Taro-Sitagliptin Fumarate

Search on Google

• Taro-Sitagliptin Fumarate side effects
• Taro-Sitagliptin Fumarate dosage
• sitagliptin side effects
• sitagliptin dosage

Taro Pharmaceuticals Inc

Go to Taro website to see drug product details. Sometimes you can find taro-sitagliptin fumarate photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.